| Trial ID: | L0128 |
| Source ID: | NCT04422496
|
| Associated Drug: |
HEC96719
|
| Title: |
The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Subjects
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-alcoholic Fatty Liver Disease|Non-alcoholic Steatohepatitis
|
| Interventions: |
Drug: HEC96719
|
| Outcome Measures: |
Adverse event|Cmax|AUC|T??|Tmax|C4|FGF19|CL/F
|
| Sponsor/Collaborators: |
Sunshine Lake Pharma Co., Ltd.
|
| Gender: |
All
|
| Age: |
18 Years to 55 Years ?? (Adult)
|
| Phases: |
Phase 1
|
| Enrollment: |
73
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment
|
| Start Date: |
August 10, 2020
|
| Completion Date: |
February 23, 2021
|
| Results First Posted: |
--
|
| Last Update Posted: |
May 7, 2021
|
| Locations: |
Nucleus Network Pty Ltd, Melbourne, Melbourne VIC 3004, Australia
|
| URL: |
https://ClinicalTrials.gov/show/NCT04422496
|
